Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems
Autor Stuart O. Schweitzer, Z. John Luen Limba Engleză Hardback – 7 iun 2018
Preț: 555.73 lei
Preț vechi: 632.05 lei
-12% Nou
Puncte Express: 834
Preț estimativ în valută:
106.35€ • 109.72$ • 90.01£
106.35€ • 109.72$ • 90.01£
Carte tipărită la comandă
Livrare economică 22-28 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780190623784
ISBN-10: 0190623780
Pagini: 432
Dimensiuni: 160 x 236 x 28 mm
Greutate: 0.75 kg
Ediția:3
Editura: Oxford University Press
Colecția OUP USA
Locul publicării:New York, United States
ISBN-10: 0190623780
Pagini: 432
Dimensiuni: 160 x 236 x 28 mm
Greutate: 0.75 kg
Ediția:3
Editura: Oxford University Press
Colecția OUP USA
Locul publicării:New York, United States
Recenzii
Schweitzer and Lu's new edition provides a broad and timely overview of pharmaceutical economics and policy issues. Topics of particular current interest include biotechnology and biosimilars, international differences in drug prices and regulations, and the contribution and affordability of new medical advances.
A must have if you are seriously interested in the domestic and international pharmaceutical industry.
This book is easy to read and provides an excellent overview of the pharmaceutical industry This book makes a useful contribution to anyone interested in understanding pharmaeconomic theory and the characteristics of the pharmaceutical industry.
A must have if you are seriously interested in the domestic and international pharmaceutical industry.
This book is easy to read and provides an excellent overview of the pharmaceutical industry This book makes a useful contribution to anyone interested in understanding pharmaeconomic theory and the characteristics of the pharmaceutical industry.
Notă biografică
Stuart O. Schweitzer is Professor of Health Policy and Management at UCLA's Fielding School of Public Health. He has held other academic and research appointments at the Urban Institute and the White House Commission for a National Agenda for the Eighties. His research and consulting activities have dealt with pharmaceutical regulation and policy, health care financing, and technology assessment.Z. John Lu is an Assistant Professor of Economics at the MVS School of Business and Economics, California State University, Channel Islands. Prior to this academic position, Dr. Lu was a health economist in the biopharmaceutical industry for 2 decades, including nearly 17 years at Amgen, where he was a director of global health economics and policy. Professor Lu's research interests include industrial economics and policy on pharmaceuticals, particularly in the United States and China.